Does TOFACITINIB Cause Skin discolouration? 305 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 305 reports of Skin discolouration have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.2% of all adverse event reports for TOFACITINIB.
305
Reports of Skin discolouration with TOFACITINIB
0.2%
of all TOFACITINIB reports
1
Deaths
41
Hospitalizations
How Dangerous Is Skin discolouration From TOFACITINIB?
Of the 305 reports, 1 (0.3%) resulted in death, 41 (13.4%) required hospitalization, and 14 (4.6%) were considered life-threatening.
Is Skin discolouration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 305 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Skin discolouration?
ADAPALENE (2,541)
DUPILUMAB (2,121)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (2,102)
ADALIMUMAB (1,598)
LENALIDOMIDE (1,566)
ETANERCEPT (1,051)
CAPECITABINE (836)
SECUKINUMAB (828)
METHOTREXATE (545)
APIXABAN (391)
Which TOFACITINIB Alternatives Have Lower Skin discolouration Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN